CIL Isotope Separations, LLC – FDA 483, Jan 25, 2022
CIL Isotope Separations, LLC in Xenia, OH, a finished API manufacturer, was cited for significant deficiencies related to equipment and material suitability, environmental controls, and facility qualification during an FDA inspection. The inspection revealed issues including an unvalidated water system with high bioburden, inadequate differential pressure controls leading to air contamination, and an unqualified HVAC system, all impacting the production of Urea-13C. This is a repeat observation regarding equipment and material suitability.
ID · 0b5b94cd-d35c-4baf-82f0-258214724262
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.